Disease The intractable diseases designated by MHLW, Japan
Diseases : 338 - Clinical trials : 34,520 / Drugs : 19,957 - ( DrugBank : 2,195 ) / Drug target genes : 613 - Drug target pathways : 297
Disease group: Ear, nose, and throat diseases| ID | Disease name [Group] | Clinical trial Phase 1 / 2 / 3 / 4 | Drug [ DrugBank ] | Target gene Target pathway | Domestic patients (1) MHLW, (2) Med expenses recipients (FY2021) |
|---|---|---|---|---|---|
| 303 | Usher syndrome [Eye] 💬 [Ear] 💬 | 10 10 trials 6 / 10 / 2 / 0 💬 | 11 11 drugs [ 0 - ] | 0 - | 20 (1) About 8,160 patients (2) 20 patients Age distribution  💬 |
| 304 | Juvenile-onset bilateral sensorineural hearing loss [Ear] 💬 | 0 - | 0 - | 0 - | 42 (1) About 4,000 patients (2) 42 patients Age distribution  💬 |
| 305 | Delayed endolymphatic hydrops [Ear] 💬 | 1 1 trial 0 / 0 / 0 / 0 💬 | 1 1 drug [ 1 1 drug ] | 0 - | 27 (1) About 4,000~5,000 patients (2) 27 patients Age distribution  💬 |
| 306 | Eosinophilic sinusitis [Imm] 💬 [Ear] 💬 | 0 - | 0 - | 0 - | 17525 (1) About 20,000 patients (2) 17,525 patients Age distribution  💬 |